IDEAS home Printed from https://ideas.repec.org/a/nat/nature/v608y2022i7922d10.1038_s41586-022-05103-3.html
   My bibliography  Save this article

Author Correction: Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies

Author

Listed:
  • Dami A. Collier

    (Cambridge Institute of Therapeutic Immunology & Infectious Disease
    University of Cambridge
    University College London)

  • Anna Marco

    (Humabs Biomed SA, a subsidiary of Vir Biotechnology)

  • Isabella A. T. M. Ferreira

    (Cambridge Institute of Therapeutic Immunology & Infectious Disease
    University of Cambridge)

  • Bo Meng

    (Cambridge Institute of Therapeutic Immunology & Infectious Disease
    University of Cambridge)

  • Rawlings P. Datir

    (Cambridge Institute of Therapeutic Immunology & Infectious Disease
    University of Cambridge
    University College London)

  • Alexandra C. Walls

    (University of Washington)

  • Steven A. Kemp

    (Cambridge Institute of Therapeutic Immunology & Infectious Disease
    University of Cambridge
    University College London)

  • Jessica Bassi

    (Humabs Biomed SA, a subsidiary of Vir Biotechnology)

  • Dora Pinto

    (Humabs Biomed SA, a subsidiary of Vir Biotechnology)

  • Chiara Silacci-Fregni

    (Humabs Biomed SA, a subsidiary of Vir Biotechnology)

  • Siro Bianchi

    (Humabs Biomed SA, a subsidiary of Vir Biotechnology)

  • M. Alejandra Tortorici

    (University of Washington)

  • John Bowen

    (University of Washington)

  • Katja Culap

    (Humabs Biomed SA, a subsidiary of Vir Biotechnology)

  • Stefano Jaconi

    (Humabs Biomed SA, a subsidiary of Vir Biotechnology)

  • Elisabetta Cameroni

    (Humabs Biomed SA, a subsidiary of Vir Biotechnology)

  • Gyorgy Snell

    (Vir Biotechnology)

  • Matteo S. Pizzuto

    (Humabs Biomed SA, a subsidiary of Vir Biotechnology)

  • Alessandra Franzetti Pellanda

    (Clinica Luganese Moncucco)

  • Christian Garzoni

    (Clinica Luganese Moncucco)

  • Agostino Riva

    (University of Milan)

  • Anne Elmer

    (NIHR Cambridge Clinical Research Facility)

  • Nathalie Kingston

    (NIHR Bioresource)

  • Barbara Graves

    (NIHR Bioresource)

  • Laura E. McCoy

    (University College London)

  • Kenneth G. C. Smith

    (Cambridge Institute of Therapeutic Immunology & Infectious Disease
    University of Cambridge)

  • John R. Bradley

    (University of Cambridge
    NIHR Bioresource)

  • Nigel Temperton

    (University of Kent)

  • Lourdes Ceron-Gutierrez

    (Addenbrooke’s Hospital)

  • Gabriela Barcenas-Morales

    (Addenbrooke’s Hospital
    Laboratorio de Inmunologia, UNAM)

  • William Harvey

    (University of Glasgow)

  • Herbert W. Virgin

    (Vir Biotechnology)

  • Antonio Lanzavecchia

    (Humabs Biomed SA, a subsidiary of Vir Biotechnology)

  • Luca Piccoli

    (Humabs Biomed SA, a subsidiary of Vir Biotechnology)

  • Rainer Doffinger

    (Addenbrooke’s Hospital
    University of Cambridge)

  • Mark Wills

    (University of Cambridge)

  • David Veesler

    (University of Washington)

  • Davide Corti

    (Humabs Biomed SA, a subsidiary of Vir Biotechnology)

  • Ravindra K. Gupta

    (Cambridge Institute of Therapeutic Immunology & Infectious Disease
    University of Cambridge
    University of Cambridge
    University of KwaZulu Natal)

Abstract

No abstract is available for this item.

Suggested Citation

  • Dami A. Collier & Anna Marco & Isabella A. T. M. Ferreira & Bo Meng & Rawlings P. Datir & Alexandra C. Walls & Steven A. Kemp & Jessica Bassi & Dora Pinto & Chiara Silacci-Fregni & Siro Bianchi & M. A, 2022. "Author Correction: Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies," Nature, Nature, vol. 608(7922), pages 24-24, August.
    • Handle: RePEc:nat:nature:v:608:y:2022:i:7922:d:10.1038_s41586-022-05103-3
    DOI: 10.1038/s41586-022-05103-3
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41586-022-05103-3
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1038/s41586-022-05103-3?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:608:y:2022:i:7922:d:10.1038_s41586-022-05103-3. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.